Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.

Kubben, F J G M; Sier, C F M; van Duijn, W; Griffioen, G; Hanemaaijer, R; van de Velde, C J H; van Krieken, J H J M; Lamers, C B H W; Verspaget, H W

Kubben, F J G M; Sier, C F M; van Duijn, W; Griffioen, G; Hanemaaijer, R; van de Velde, C J H; van Krieken, J H J M; Lamers, C B H W; Verspaget, H W.

Affiliation

Kubben FJ; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Building 1, C4-P012, PO Box 9600, 2300 RC Leiden, The Netherlands.

Br J Cancer ; 94(7): 1035-40, 2006 Apr 10.

Article in En | MEDLINE | ID: mdl-16538217

Subject(s)

Matrix Metalloproteinase 2/analysis; Stomach Neoplasms/enzymology; Stomach Neoplasms/pathology; Adult; Aged; Aged, 80 and over; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Matrix Metalloproteinase 2 Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2006 Document type: Article

Fulltext

XML

PubMed Links

Search on Google